Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Fierce Pharma
JPM26: Leo Pharma sharpens its eye for dermatology dealmaking
Leo Pharma CEO Christophe Bourdon is eager to make additional strides on the new era of growth he’s fostered since taking over in 2022.
Zoey Becker
Jan 13, 2026 2:45pm
Baby KJ scientist launches personalized CRISPR therapy startup
Jan 9, 2026 8:42am
Foresee offloads clinical-stage MMP-12 inhibitors in $584M deal
Jan 8, 2026 7:45am
Series B round of $125M will fund Diagonal's move into clinic
Jan 8, 2026 6:30am
Fierce Pharma
3 biopharma CEOs explain why they are 'authentically optimistic'
Jan 6, 2026 11:54am
Neuro biotech Nido closes after 5 years
Jan 2, 2026 10:24am
